TL1 Training Grant

Program Overview


Wayne McCormack, Ph.D., TL1 Program Director, (top left) and David Nelson, M.D., Director of the CTSI, (top right) pose with TL1 Trainees at CTSI Research Day 2014. TL1 Trainees clockwise from bottom right: Aliyah Snyder, Cuc Tran, Margo Klar, Corey Simon and Martin Wegman. Not pictured: Dane Phelan, Shannon Roff and Jacquelyn Walejko.

The CTSI TL1 Predoctoral Training Program provides junior trainees with the skills required to develop a career in multidisciplinary clinical and translational research. The program uses a team-science approach and provides mentoring and didactic training for predoctoral students performing clinical and/or translational research in health-related fields at UF.

TL1 trainees will initially receive one year of funding, including a stipend (current year level: $22,476*), tuition waiver, and GatorGradCare health insurance via a Graduate Research Assistantship; $2,500 for lab and training-related expenses; and a $1,500 travel allowance to attend and present research at the annual Translational Science conference. A second year of funding may be awarded based on performance, progress and available funding.

Contact the program with any questions at

*If a TL1 trainee’s current stipend is above $22,476, a mentor should supplement the stipend from non-federal funds to the original stipend level.

Eligibility Requirements

  1. Applicants must be U.S. citizens or permanent residents per NIH policy and entering their second or third year of doctoral graduate study. Students from populations underrepresented in the biomedical, clinical, behavioral and social sciences are encouraged to apply (more information).
  2. Doctoral students from the following partner graduate programs spanning 11 colleges are eligible to apply.  Additional partner programs can be added, so applications from students in other relevant graduate programs may be considered.
    • Agricultural & Life Sciences: Nutritional Sciences
    • Dentistry: DMD-PhD Program
    • Engineering: Biomedical Engineering, Materials Science & Engineering
    • Health & Human Performance: Applied Physiology & Kinesiology, Health Education & Behavior
    • Journalism & Communications: Mass Communication
    • Liberal Arts & Sciences: Chemistry
    • Medicine: Interdisciplinary Program in Biomedical Sciences (Biochemistry & Molecular Biology, Cancer Biology, Genetics, Immunology & Microbiology, Molecular Cell Biology, Neuroscience, Physiology & Pharmacology), M.D.-Ph.D. Program, Health Outcomes & Policy
    • Nursing: Nursing Science
    • Pharmacy: Medicinal Chemistry, Pharmaceutics, Pharmacodynamics, Pharmaceutical Outcomes and Policy, Clinical Pharmaceutical Sciences
    • Public Health & Health Professions: Clinical and Health Psychology, Rehabilitation Science
    • Veterinary Medicine: Veterinary Medical Sciences
    • Multi-College Programs: Epidemiology, Genetics & Genomics
  3. Applicants must apply in the first or second year of Ph.D. studies, prior to completing doctoral candidacy exams.
  4. Applicants should have strong academic credentials and good communication skills.
  5. Applicants must be able to commit to all course and research training requirements of the training program.
  6. Applicants must propose a research project relevant to human health, which should include at least one component of clinical and/or translational research as defined by the NIH.
  7. Applicants should demonstrate interest in developing a career in multidisciplinary, translational biomedical research.
  8. Applicants must identify two faculty mentors (one basic science and one clinical/translational) and demonstrate strong mentor support.

Program Requirements

TL1 Trainees must:

Application Process

Applicants must assemble an application packet that includes a completed TL1 application form and supporting materials, which include applicant statements; a research plan for the proposed research project, which must have both clinical/ translational and basic science components; and supporting materials from two proposed mentors (one basic science mentor and one clinical & translational science mentor).  Finalists are interviewed by the TL1 Advisory Committee.

New applications must be submitted electronically by 5:00 p.m. on Monday, June 29, 2015.  Paper documents will not be accepted.  Interviews of finalists will take place in early July, 2015, and awards are expected to be announced no later than July 31, 2015.    TL1 application form


  1. Clinical Research: Patient-oriented research, including epidemiologic and behavioral studies, outcomes research, and health services research. Patient-oriented research is research conducted with human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) in which a researcher directly interacts with human subjects. It includes research on mechanisms of human disease, therapeutic interventions, clinical trials, and development of new technologies, but does not include in vitro studies using human tissues not linked to a living individual. Studies falling under 45 CFR 46.101(b) (4) are not considered clinical research for purposes of this definition. (Source:
  2. Translational Research: Translational research includes two areas of translation. One is the process of applying discoveries generated during research in the laboratory, and in preclinical studies, to the development of trials and studies in humans. The second area of translation concerns research aimed at enhancing the adoption of best practices in the community. Cost-effectiveness of prevention and treatment strategies is also an important part of translational science. (Source:
  3. Permanent Resident: someone who has been granted authorization to live and work in the United States on a permanent basis. As proof of that status, a person is granted a permanent resident card, commonly called a “green card.” (Source: US Citizen and Immigration Services)